| Morphine, gabapentin, or their combination for neuropathic pain I Gilron, JM Bailey, D Tu, RR Holden, DF Weaver, RL Houlden New England Journal of Medicine 352 (13), 1324-1334, 2005 | 1450 | 2005 |
| A comparison of methods for modeling quantitative structure− activity relationships JJ Sutherland, LA O'Brien, DF Weaver Journal of Medicinal Chemistry 47 (22), 5541-5554, 2004 | 276 | 2004 |
| Spline-fitting with a genetic algorithm: A method for developing classification structure− activity relationships JJ Sutherland, LA O'brien, DF Weaver Journal of chemical information and computer sciences 43 (6), 1906-1915, 2003 | 252 | 2003 |
| Medicinal chemistry: a molecular and biochemical approach T Nogrady, DF Weaver Oxford University Press, 2005 | 209 | 2005 |
| β-Alanine as a small molecule neurotransmitter KE Tiedje, K Stevens, S Barnes, DF Weaver Neurochemistry international 57 (3), 177-188, 2010 | 208 | 2010 |
| The blood–brain barrier (BBB) score M Gupta, HJ Lee, CJ Barden, DF Weaver Journal of medicinal chemistry 62 (21), 9824-9836, 2019 | 192 | 2019 |
| The development of new therapeutics for Alzheimer's disease MD Carter, GA Simms, DF Weaver Clinical Pharmacology & Therapeutics 88 (4), 475-486, 2010 | 147 | 2010 |
| Massive carbamazepine overdose: clinical and pharmacologic observations in five episodes DF Weaver, P Camfield, A Fraser Neurology 38 (5), 755-755, 1988 | 130 | 1988 |
| Some aryl semicarbazones possessing anticonvulsant activitie JR Dimmock, KK Sidhu, SD Tumber, SK Basran, M Chen, JW Quail, ... European journal of medicinal chemistry 30 (4), 287-301, 1995 | 128 | 1995 |
| Characterization of aromatic-thiol π-type hydrogen bonding and phenylalanine-cysteine side chain interactions through ab initio calculations and protein database … G Duan, VH Smith Jr, DF Weaver Molecular Physics 99 (19), 1689-1699, 2001 | 113 | 2001 |
| Structural aspects of Congo Red as an inhibitor of protease‐resistant prion protein formation R Demaimay, J Harper, H Gordon, D Weaver, B Chesebro, B Caughey Journal of neurochemistry 71 (6), 2534-2541, 1998 | 113 | 1998 |
| Method for treating amyloidosis R Kisilevsky, W Szarek, D Weaver US Patent 5,643,562, 1997 | 106 | 1997 |
| The bioisosteric similarity of the tetrazole and carboxylate anions: clues from the topologies of the electrostatic potential and of the electron density CF Matta, AA Arabi, DF Weaver European journal of medicinal chemistry 45 (5), 1868-1872, 2010 | 100 | 2010 |
| Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations JJ Sutherland, LA O’Brien, D Lillicrap, DF Weaver Journal of molecular modeling 10, 259-270, 2004 | 99 | 2004 |
| Reciprocal modulation of TrkA and p75NTR affinity states is mediated by direct receptor interactions GM Ross, IL Shamovsky, G Lawrance, M Solc, SM Dostaler, DF Weaver, ... European Journal of Neuroscience 10 (3), 890-898, 1998 | 96 | 1998 |
| A one-pot synthesis of 3-amino-3-arylpropionic acids CYK Tan, DF Weaver Tetrahedron 58 (37), 7449-7461, 2002 | 93 | 2002 |
| Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins GM Ross, IL Shamovsky, G Lawrance, M Solc, SM Dostaler, SL Jimmo, ... Nature medicine 3 (8), 872-878, 1997 | 93 | 1997 |
| Improving the clinical assessment of consciousness with advances in electrophysiological and neuroimaging techniques JR Gawryluk, RCN D'Arcy, JF Connolly, DF Weaver BMC neurology 10, 1-7, 2010 | 92 | 2010 |
| Eosinophil‐induced neurotoxicity: Axonal neuropathy, cerebral infarction, and dementia DF Weaver, LP Heffernan, RA Purdy, VW Ing Neurology 38 (1), 144-144, 1988 | 91 | 1988 |
| Aspartame exacerbates EEG spike‐wave discharge in children with generalized absence epilepsy: A double‐blind controlled study PR Camfield, CS Camfield, JM Dooley, K Gordon, S Jollymore, ... Neurology 42 (5), 1000-1000, 1992 | 90 | 1992 |
